ACADIA Pharmaceuticals to Announce Third Quarter 2014 Financial Results on November 10, 2014

ACADIA to Host Conference Call and Webcast on Monday, November 10,2014, at 5:00 p.m. Eastern Time

SAN DIEGO—(BUSINESS WIRE)—Nov. 3, 2014—ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical companyfocused on the development and commercialization of innovative medicinesthat address unmet medical needs in neurological and related centralnervous system disorders, today announced that it will report itsunaudited financial results for the third quarter ended September 30,2014 on Monday, November 10, 2014, after the U.S. financial marketsclose. ACADIA's management will host a conference call and webcast onMonday, November 10, 2014, at 5:00 p.m. Eastern Time to discuss ACADIA’sfinancial results and development programs.

The conference call may be accessed by dialing 866-318-8615 forparticipants in the United States or Canada and 617-399-5134 forinternational callers (reference passcode 86826740). A telephone replayof the conference call may be accessed through November 24, 2014 bydialing 888-286-8010 for callers in the United States or Canada and617-801-6888 for international callers (reference passcode 62605343).The conference call also will be webcast live on ACADIA’s website, www.acadia-pharm.comunder the investors section and will be archived there until November24, 2014.

Source: ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals Inc.
Steve Davis, Executive VicePresident,
Chief Financial Officer and Chief Business Officer
LisaBarthelemy, Director of Investor Relations
858-558-2871